Rxo Net Debt Growth & History (RXO)

Rxo's net debt was $653.0M for fiscal 2025.

View full Rxo company overview

Rxo annual net debt history

Rxo annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31$653.0M$24.0M+3.82%
20242024-12-31$629.0M$76.0M+13.74%
20232023-12-31$553.0M$34.0M+6.55%
20222022-12-31$519.0M$413.0M+389.62%
20212021-12-31$106.0M

Rxo net debt trends

Between the periods ended 2021-12-31 and 2025-12-31, Rxo's net debt increased from $106.0M to $653.0M, a change of $547.0M. The latest reported quarter, Q2 2026, shows $713.0M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Rxo source filings ↗

Community posts

It’s quiet here.

No posts about RXO yet. Start the conversation.

Write the first post